A phase 2a, single‐arm, open‐label study of tafasitamab, a humanized, Fc‐modified, anti‐CD19 antibody, in patients with relapsed/refractory B‐precursor cell acute lymphoblastic leu...

por Klisovic, Rebecca B., Leung, Wing H., Brugger, Wolfram, Dirnberger‐Hertweck, Maren, Winderlich, Mark, Ambarkhane, Sumeet V., Jabbour, Elias J.
Publicado 2021

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer

por Stein, Alexander, Atanackovic, Djordje, Hildebrandt, Bert, Stübs, Patrick, Brugger, Wolfram, Hapke, Gunnar, Steffens, Claus-Christoph, Illerhaus, Gerald, Bluemner, Ernst, Stöhlmacher, Jan, Bokemeyer, Carsten
Publicado 2015

Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel – an update

por Cheson, Bruce D., Brugger, Wolfram, Damaj, Gandhi, Dreyling, Martin, Kahl, Brad, Kimby, Eva, Ogura, Michinori, Weidmann, Eckhart, Wendtner, Clemens-Martin, Zinzani, Pier Luigi
Publicado 2016

Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy

por Rittig, Susanne M., Haentschel, Maik, Weimer, Katrin J., Heine, Annkristin, Müller, Martin R., Brugger, Wolfram, Horger, Marius S., Maksimovic, Olga, Stenzl, Arnulf, Hoerr, Ingmar, Rammensee, Hans-Georg, Holderried, Tobias A., Kanz, Lothar, Pascolo, Steve, Brossart, Peter
Publicado 2015

Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)

por Rummelt, Christoph, Grishina, Olga, Schmoor, Claudia, Crysandt, Martina, Heuser, Michael, Götze, Katharina S., Schlenk, Richard F., Döhner, Konstanze, Salih, Helmut R., Heil, Gerhard, Müller-Tidow, Carsten, Brugger, Wolfram, Kündgen, Andrea, de Wit, Maike, Giagounidis, Aristoteles, Scholl, Sebastian, Neubauer, Andreas, Krauter, Jürgen, Bug, Gesine, Al-Ali, Haifa Kathrin, Wäsch, Ralph, Becker, Heiko, May, Annette M., Duyster, Justus, Hackanson, Björn, Ganser, Arnold, Döhner, Hartmut, Lübbert, Michael
Publicado 2023

Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma

por Roddie, Claire, Lekakis, Lazaros J., Marzolini, Maria A. V., Ramakrishnan, Aravind, Zhang, Yiyun, Hu, Yanqing, Peddareddigari, Vijay G. R., Khokhar, Nushmia, Chen, Robert, Basilico, Silvia, Raymond, Meera, Vargas, Frederick Arce, Duffy, Kevin, Brugger, Wolfram, O’Reilly, Maeve A., Wood, Leigh, Linch, David C., Peggs, Karl S., Bachier, Carlos, Budde, Elizabeth Lihua, Lee Batlevi, Connie, Bartlett, Nancy, Irvine, David, Tholouli, Eleni, Osborne, Wendy, Ardeshna, Kirit M., Pule, Martin A.
Publicado 2023

S262: SAFETY AND EFFICACY OF OBECABTAGENE AUTOLEUCEL (OBE-CEL), A FAST-OFF RATE CD19 CAR IN RELAPSED/REFRACTORY ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA:TOP LINE RESULTS OF THE P...

por Roddie, Claire, Sandhu, Karamjeet, Tholouli, Eleni, Shaughnessy, Paul, Barba Suñol, Pere, Nuno Direito de Morais Guerreiro, Manuel, Abedi, Mehrdad, Bishop, Michael, Yared, Jean, Ghobadi, Armin, Yallop, Deborah, Logan, Aaron, Amer, Beitinjaneh, Pantin, Jeremy, Arellano, Martha L, Chaganti, Sridhar, Malladi, Ram, Menne, Tobias, Escamilla, Virginia, Hodby, Katharine, Gundabolu, Krishna, Mountjoy, Luke, Odwyer, Kristen, Abedin, Sameem, Alkhateeb, Hassan, Shah, Bijal, Basilico, Silvia, Cluxton, Deborah, Dawes, Joanna, Lao-Sirieix, Pierre, Raymond, Meera, Shang, Justin, Hu, Yanqing, Pittari, Gianfranco, Saxena, Kapil, Brugger, Wolfram, Zhang, Y, Pule, Martin, Park, Daniel, De Angelo, Daniel, Jabbour, Elias
Publicado 2023